Switch from Immediate-release Pramipexole to Extended-release Pramipexole: The Safety and Efficacy Characteristics of Sixty-eight Patients

KUZU M., ÖZER İ. Ş., TEZCAN S., HERDİ O., AKBOSTANCI M. C.

Turkish Journal Of Neurology, cilt.22, sa.3, ss.114-116, 2016 (ESCI, Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 3
  • Basım Tarihi: 2016
  • Doi Numarası: 10.4274/tnd.48751
  • Dergi Adı: Turkish Journal Of Neurology
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.114-116
  • Anahtar Kelimeler: Parkinson disease, dopamine agonist, extended-release pramipexole, RANDOMIZED CONTROLLED-TRIAL, PARKINSONS-DISEASE, AGONIST
  • Lokman Hekim Üniversitesi Adresli: Hayır

Özet

Objective: To evaluate the safety and efficacy of switching from immediate-release pramipexole (pex) to extended-release pramipexole (pex-ER).